Elutia (ELUT) News Today $4.38 +0.17 (+4.04%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Elutia's (ELUT) Overweight Rating Reiterated at Cantor FitzgeraldNovember 19 at 1:43 AM | americanbankingnews.comElutia Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues LagNovember 17, 2024 | uk.finance.yahoo.comQ3 2024 Elutia Inc Earnings CallNovember 15, 2024 | finance.yahoo.comElutia Inc. Reports Strong Q3 Results, Prepares for Major Product LaunchNovember 15, 2024 | markets.businessinsider.comElutia's (ELUT) "Overweight" Rating Reiterated at Cantor FitzgeraldCantor Fitzgerald restated an "overweight" rating and set a $10.00 price target on shares of Elutia in a report on Friday.November 15, 2024 | marketbeat.comElutia reports Q3 EPS (33c) vs (57c) last yearNovember 14, 2024 | markets.businessinsider.comElutia Inc. (ELUT) Q3 2024 Earnings Call TranscriptNovember 14, 2024 | seekingalpha.comElutia Announces Strong Third Quarter Results, Accelerating Toward Full Launch of EluPro® Antibiotic-Eluting BioEnvelope in 2025November 14, 2024 | markets.businessinsider.comElutia to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumNovember 13, 2024 | markets.businessinsider.comElutia (ELUT) to Release Quarterly Earnings on ThursdayNovember 13, 2024 | americanbankingnews.comElutia (ELUT) Set to Announce Quarterly Earnings on ThursdayElutia (NASDAQ:ELUT) will be releasing earnings after the market closes on Thursday, November 14, Zacks reports.November 12, 2024 | marketbeat.comElutia Inc. (NASDAQ:ELUT) Short Interest UpdateElutia Inc. (NASDAQ:ELUT - Get Free Report) was the recipient of a significant increase in short interest in October. As of October 15th, there was short interest totalling 108,200 shares, an increase of 7.4% from the September 30th total of 100,700 shares. Based on an average trading volume of 48,700 shares, the short-interest ratio is currently 2.2 days. Approximately 0.6% of the shares of the company are short sold.November 1, 2024 | marketbeat.comElutia to Present at the LD Micro Main Event XVII Conference on Wednesday, October 30October 23, 2024 | globenewswire.comSILVERARC CAPITAL MANAGEMENT, LLC Acquires Shares in Elutia IncOctober 15, 2024 | finance.yahoo.comNantahala Capital Management LLC Grows Stock Position in Elutia Inc. (NASDAQ:ELUT)Nantahala Capital Management LLC lifted its stake in Elutia Inc. (NASDAQ:ELUT - Free Report) by 8.8% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,795,697 shares of the company's stock after buying an additional 14October 1, 2024 | marketbeat.comShort Interest in Elutia Inc. (NASDAQ:ELUT) Declines By 30.1%Elutia Inc. (NASDAQ:ELUT - Get Free Report) was the target of a large decrease in short interest during the month of September. As of September 15th, there was short interest totalling 70,500 shares, a decrease of 30.1% from the August 31st total of 100,800 shares. Based on an average trading volume of 69,100 shares, the short-interest ratio is currently 1.0 days. Currently, 0.4% of the shares of the stock are sold short.September 27, 2024 | marketbeat.comECU Health pioneers with FDA-approved EluPro BioEnvelope in pacemaker implantationSeptember 21, 2024 | msn.comElutia Announces New Peer Reviewed Publication Highlighting the Robustness of EluPro™, Company's Antibiotic-Eluting BioEnvelope for Implantable DevicesSeptember 18, 2024 | globenewswire.comShort Interest in Elutia Inc. (NASDAQ:ELUT) Decreases By 10.9%Elutia Inc. (NASDAQ:ELUT - Get Free Report) was the target of a significant decline in short interest during the month of August. As of August 31st, there was short interest totalling 100,800 shares, a decline of 10.9% from the August 15th total of 113,100 shares. Approximately 0.6% of the company's stock are sold short. Based on an average trading volume of 82,800 shares, the days-to-cover ratio is currently 1.2 days.September 17, 2024 | marketbeat.comAIGH Capital Management LLC Buys 1,260,750 Shares of Elutia Inc. (NASDAQ:ELUT)AIGH Capital Management LLC boosted its position in Elutia Inc. (NASDAQ:ELUT - Free Report) by 288.8% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,697,316 shares of the company's stocSeptember 9, 2024 | marketbeat.comElutia Celebrates First YearSeptember 6, 2024 | globenewswire.comElutia (NASDAQ:ELUT) Receives Overweight Rating from Cantor FitzgeraldCantor Fitzgerald restated an "overweight" rating and set a $10.00 target price on shares of Elutia in a research note on Friday.September 6, 2024 | marketbeat.comElutia Announces First Patient Implant of EluPro™, the World's First Drug-Eluting BioEnvelope for Cardiac Pacemakers and NeurostimulatorsSeptember 5, 2024 | globenewswire.comElutia to Participate in Upcoming Investor ConferencesSeptember 3, 2024 | globenewswire.comElutia Inc. (ELUT) Q2 2024 Earnings Call TranscriptAugust 12, 2024 | seekingalpha.comElutia earnings missed by $0.78, revenue fell short of estimatesAugust 9, 2024 | investing.comElutia (NASDAQ:ELUT) Price Target Cut to $10.00Cantor Fitzgerald reduced their price objective on shares of Elutia from $11.00 to $10.00 and set an "overweight" rating for the company in a research note on Thursday.August 8, 2024 | marketbeat.comELUT Stock Earnings: Elutia Misses EPS, Misses Revenue for Q2 2024August 7, 2024 | markets.businessinsider.comElutia Announces Second Quarter 2024 ResultsAugust 7, 2024 | finance.yahoo.comElutia Announces Full Exercise of Warrants Generating $15.7 Million in Gross ProceedsAugust 1, 2024 | markets.businessinsider.comElutia Appoints Ryan Marques, Ph.D., MBA as Vice President of OperationsJuly 31, 2024 | globenewswire.comElutia (ELUT) Set to Announce Quarterly Earnings on WednesdayElutia (NASDAQ:ELUT) will be releasing earnings after the market closes on Wednesday, August 7, Zacks reports.July 31, 2024 | marketbeat.comBeat the Market Like Zacks: Karooooo, UnitedHealth, Amgen in FocusJuly 22, 2024 | msn.comElutia to Present at the Emerging Growth Conference on Thursday, July 18July 11, 2024 | globenewswire.com7 Growth Stocks to Buy for Under $5 for Massive GainsJuly 11, 2024 | investorplace.comLake Street Capital Raises Elutia (NASDAQ:ELUT) Price Target to $10.00Lake Street Capital lifted their target price on Elutia from $5.00 to $10.00 and gave the company a "buy" rating in a research report on Friday.June 21, 2024 | marketbeat.comElutia (NASDAQ:ELUT) Price Target Raised to $11.00 at Cantor FitzgeraldCantor Fitzgerald lifted their target price on shares of Elutia from $5.00 to $11.00 and gave the company an "overweight" rating in a research note on Tuesday.June 18, 2024 | marketbeat.comElutia Announces $13.26 Million Registered Direct OfferingJune 17, 2024 | globenewswire.comElutia Announces FDA Clearance of EluPro®: The First Antibiotic-Eluting BioEnvelope Designed to Protect Patients with Implantable Cardiac Pacemakers and DefibrillatorsJune 17, 2024 | globenewswire.comElutia Inc. (NASDAQ:ELUT) Short Interest Down 62.4% in MayElutia Inc. (NASDAQ:ELUT - Get Free Report) was the recipient of a large drop in short interest during the month of May. As of May 31st, there was short interest totalling 7,300 shares, a drop of 62.4% from the May 15th total of 19,400 shares. Currently, 0.1% of the shares of the company are short sold. Based on an average daily trading volume, of 16,200 shares, the short-interest ratio is currently 0.5 days.June 12, 2024 | marketbeat.comElutia (NASDAQ:ELUT) Trading Up 1.7%Elutia (NASDAQ:ELUT) Trading Up 1.7%June 7, 2024 | marketbeat.comElutia to Showcase BioEnvelope Product Line at Heart Rhythm 2024May 13, 2024 | finance.yahoo.comElutia (NASDAQ:ELUT) PT Lowered to $5.00 at Cantor FitzgeraldCantor Fitzgerald cut their price objective on Elutia from $6.00 to $5.00 and set an "overweight" rating on the stock in a research report on Friday.May 10, 2024 | marketbeat.comELUT Stock Earnings: Elutia Misses EPS, Beats Revenue for Q1 2024May 10, 2024 | investorplace.comElutia Announces First Quarter 2024 Results: SimpliDerm® Sales Increase 55%, CanGaroo®RM on Track for Second Quarter 2024 FDA ClearanceMay 9, 2024 | finance.yahoo.comElutia to Report First Quarter 2024 Financial Results on Thursday, May 9, 2024May 2, 2024 | finance.yahoo.comElutia to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1April 24, 2024 | globenewswire.comShort Interest in Elutia Inc. (NASDAQ:ELUT) Decreases By 43.1%Elutia Inc. (NASDAQ:ELUT - Get Free Report) was the recipient of a significant decrease in short interest in March. As of March 15th, there was short interest totalling 12,800 shares, a decrease of 43.1% from the February 29th total of 22,500 shares. Based on an average daily trading volume, of 25,900 shares, the short-interest ratio is presently 0.5 days. Currently, 0.1% of the shares of the company are sold short.March 28, 2024 | marketbeat.comElutia Inc.: Elutia Reports Fourth Quarter and Full Year 2023 Financial Results: Anticipates CanGarooRM Clearance Decision in First Half of 2024March 10, 2024 | finanznachrichten.deElutia Full Year 2023 Earnings: Misses ExpectationsMarch 10, 2024 | finance.yahoo.com Get Elutia News Delivered to You Automatically Sign up to receive the latest news and ratings for ELUT and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics… Get Your Free Gold Guide ELUT Media Mentions By Week ELUT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ELUT News Sentiment▼0.360.46▲Average Medical News Sentiment ELUT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ELUT Articles This Week▼91▲ELUT Articles Average Week Get Elutia News Delivered to You Automatically Sign up to receive the latest news and ratings for ELUT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies IGMS News Today ABVX News Today HUMA News Today ATXS News Today ORGO News Today CRVS News Today ALT News Today SANA News Today PROK News Today GLUE News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ELUT) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elutia Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Elutia With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ELUT Stock Alerts